PartnerPoint is a patient-reported outcomes measure (PROM) administered to immunoglobulin (IG) patients during intake and at each home visit that reliably evaluates patient status. This best-practice IG patient management program helps optimize therapeutic regimens and patient outcomes by increasing communication across all members of a patient’s care team and providing more critical intervention opportunities. Option Care makes clinical management data reportable and accessible to prescribing physicians, thereby increasing their ability to manage adverse drug reactions, monitor patient quality of life, optimize dosing, and demonstrate response to therapy. PartnerPoint powers disease-specific outcomes data for more than 10 IG conditions, including chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), and primary immunodeficiency disease (PID).
References: 1. Review of Option Care patient data, October 2009-February 2011. Based on an average 39,978 patients per month. 2. Review of Option Care patient data, October 2009-February 2011. Based on an average 35,731 patients per month. 3. Shelley S. Home-infusion providers struggle with unfriendly reimbursement policies. Pharm Commerce. October 10, 2009. http://pharmaceuticalcommerce.com/index.php?pg=brand_communications&articleid=1272&keyword=infusionhome%20infusionNHIAigGIVIGchronic. Accessed February 26, 2015. 4. Luszcz N, O’Neill M, Siddiqui T. Home nutrition support team interventions demonstrate improved clinical and financial outcomes. Poster presented at: Clinical Nutrition Week 2013; February 9-12, 2013; Phoenix, AZ. 5. Ayer G, Christopher-Stine L, Ladha S, et al. Validation of patient-reported outcomes in the home infusion setting in the management of patients with neuromuscular disease. Poster presented at: American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting; October 28-November 1, 2014; Savannah, GA.
Sign up to receive more information and periodic updates about Option Care.